CBD /

 

Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-BR-105280-1   |   PDF   |   Print   |  
| 
|  Close
last updated: 28 Jan 2014
Amendment
No
General Information
Brazil
Commercial release of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-IBD - Live frozen vaccine against Marek's Disease and Gumboro Disease
EN
11 Feb 2010
No
Subject of the decision, notification, communication or declaration
  • Decision on Pharmaceuticals (Article 5)
LMO identification & risk assessment
  • BCH-LMO-SCBD-105260-1 Living Modified Organism VECTORMUNE® HVT-IBD
    Ceva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
  • BCH-RA-BR-105279-1 Risk Assessment generated by a regulatory process Risk assessment of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-IBD - Live frozen vaccine against Marek's Disease and Gumboro Disease
    VECTORMUNE® HVT-IBD | Turkey herpesvirus, Meleagrid herpesvirus 1, Production of medical or pharmaceutical compounds (human or animal)
Document on the decision, communication, notification or declaration

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs UNEP eLearning Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter